Dynavax Technologies company information, Employees & Contact Information

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 Yahoo Finance

Dynavax (Nasdaq: DVAX) sets Nov. 5 results call at 4:30 p.m. ET; webcast replay available Stock Titan

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference PR Newswire

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial The AI Journal

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good (NASDAQ:DVAX) Seeking Alpha

Dynavax (NASDAQ: DVAX) starts Part 2 for Z-1018, enrolling approximately 324 vs Shingrix Stock Titan

Dynavax Comments on Glass Lewis Recommendation PR Newswire

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting Yahoo Finance

Vaccine Developer Dynavax to Showcase HEPLISAV-B and COVID-19 Programs at Wells Fargo Conference Stock Titan

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy PR Newswire

Dynavax Technologies’ Investigational Shingles Vaccine Achieves Complete Antibody Response in Phase I/II Shingles Trial Applied Clinical Trials

Dynavax Technologies: What The Stock Buyback Means, What It Doesn't (NASDAQ:DVAX) Seeking Alpha

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile Yahoo Finance

Dynavax Earnings: Vaccine Maker to Report Q2 Results as HEPLISAV-B Sales Growth Continues Stock Titan

Dynavax Announces $100 Million Accelerated Share Repurchase Program PR Newswire

Dynavax Adopts Limited-Duration Stockholder Rights Plan PR Newswire

Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire

Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook Yahoo Finance

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights Stock Titan

Dynavax elects all four of its nominees after Deep Track proxy fight Reuters

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study Reuters

Earnings call transcript: Dynavax beats Q2 2025 forecasts, stock dips Investing.com

Dynavax's shingles vaccine holds its own against GSK's Shingrix in early clinical test Fierce Biotech

CEPI and Dynavax expand collaboration to increase supply of adjuvant for COVID-19 vaccines CEPI

Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8 PNAS

FDA Issues Complete Response Letter to sBLA for Four-Dose Heplisav-B Regimen in Adults on Hemodialysis Applied Clinical Trials

Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors Reuters

Dynavax Technologies: A Dip To Accumulate (NASDAQ:DVAX) Seeking Alpha

Dynavax's feud with activist investor heats up ahead of annual meeting Fierce Biotech

Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts simplywall.st

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share Seeking Alpha

Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate PR Newswire

VC firm launches proxy fight to end Dynavax's 'empire-building' Fierce Biotech

Dynavax says shingles shot performed on par with GSK’s Shingrix in Phase 1/2 trial Seeking Alpha

Dynavax drops Tdap vaccine after considering phase 1 data, competition Fierce Biotech

Dynavax’s Z-1018 Shingles Vaccine Candidate Shows Promising Immune Response and Safety in Early Trial Pharmacy Times

Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults Yahoo Finance

FDA Issues CRL for Heplisav-B in Adults With ESRD on Hemodialyis Drug Topics

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer Nature

2001 National Champion Griz to reunite for a good cause University of Montana Athletics

Hepatitis B Vaccine Reports Similar Acute Myocardial Infarction Rate Vax-Before-Travel

Why Dynavax Technologies Stock Is Sliding Today The Motley Fool

Is the new Dynavax hepatitis vaccine safe? I couldn’t tell — and I was advising the FDA statnews.com

Dynavax at William Blair Conference: Strategic Growth Insights By Investing.com Investing.com Australia

Overall Response Rate of 76% in Advanced Melanoma Patients GlobeNewswire

Dynavax To Present At J.P. Morgan Conference; Webcast At 6:00 PM ET RTTNews

Dynavax Technologies (DVAX) Zacks Investment Research